Skip to main content
FUJI SEIKO LIMITED logo

FUJI SEIKO LIMITED — Investor Relations & Filings

Ticker · 6142 ISIN · JP3824700003 T Manufacturing
Filings indexed 71 across all filing types
Latest filing 2023-07-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 6142

About FUJI SEIKO LIMITED

https://fujiseiko.com/

FUJI SEIKO LIMITED, a part of Freudenberg Medical, specializes in the design and manufacture of high-precision metal components for the medical device industry. The company's core products include metal hypotubes, steerable components, and precision needle assemblies, which are critical for advanced minimally invasive devices. It serves medical device OEMs globally, with key applications in the cardiovascular, neurovascular, endoscopy, and structural heart fields. The company offers a range of vertically integrated capabilities, including advanced metal processing like laser cutting, welding, and grinding, as well as surface treatments such as electro-polishing and proprietary coatings. This expertise supports the entire product lifecycle, from initial concept and prototyping to high-volume manufacturing, enabling the development of complex medical instruments.

Recent filings

Filing Released Lang Actions
四半期報告書-第66期第1四半期(2023/03/01-2023/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Tokai Local Finance Bureau under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the first quarter of the 66th fiscal year (March 1, 2023, to May 31, 2023). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-07-12 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の4の8第1項' (Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a quarterly report, rather than the quarterly report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q1 2023
2023-07-12 Japanese
内部統制報告書-第65期(2022/03/01-2023/02/28)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and assessment results regarding internal controls over financial reporting. Since this is a specific regulatory filing required by law that does not fit into the categories of annual reports, earnings releases, or other specific financial disclosures, it is best classified as a Regulatory Filing (RNS).
2023-05-25 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2023
2023-05-25 Japanese
有価証券報告書-第65期(2022/03/01-2023/02/28)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It explicitly states the fiscal year (第65期, 2022-03-01 to 2023-02-28) and is filed under the Financial Instruments and Exchange Act. The content includes XBRL tags and financial disclosure structures typical of a comprehensive annual filing. FY 2023
2023-05-25 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the 3rd Quarter Report. While it references a quarterly report, the document itself is a formal regulatory filing confirming the accuracy of the financial statements, which is a standard regulatory requirement in Japan. Given it is a specific regulatory filing document rather than the quarterly report itself, it falls under the RNS category.
2023-01-11 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.